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Dr Christian Pizarro (Wilmington, Del). The report by Yun
and colleagues compares the effectiveness of RA versus BA for
the management of AF in a moderate size contemporary cohort
of adults with ASD. The article is well written and explains the ra-
tionale for a right-sided only approach in these patients on the basis
of the assumption that the left atrium is relatively free of structural
changes secondary to pressure and volume overload, and therefore
a more limited procedure could achieve the same efficacy to
restore normal rhythm while reducing the potential for operative
morbidity. However, this has not been demonstrated. The authors
conclude that at a median follow-up of 54 months, the BA appears
to be superior to treat this patient population. I have several
questions.
In the technique section you described that lesion 1 was delib-
erately omitted in 29 patients, which leads to the first question as to
how did you select these patients and did this modification result in
any benefit as anticipated?
Dr Yun. Five surgeons operated on the cohort in this study. One
of them is an adult cardiac surgeonwho has performed hundreds of
maze procedures, and he believes strongly that the right atrial au-
ricle should be preserved for the postoperative fluid management
because the right atrial auricle is thought to secrete natriuretic pep-
tide. He operated on 29 patients, and right atrial auricle resection
was deliberately omitted in these patients.
Dr Pizarro. Did you include this in the analysis to determine if
this, in fact, turns out to be true?
Dr Yun. No, I did not.
Dr Pizarro. By using multivariate analysis, you have shown
that the presence of significant TR has an important effect on the
time to the first episode of AF recurrence. As previously stated,
it is believed that the degree of atrial dilatation secondary to the
volume overload is an important contributor to the recurrence of
AF. Although closure of the ASD will remove some of the load,
it is not surprising that in patients with significant residual volume
load secondary to TR the recurrencewould be high. Can you tell us
what was the incidence of postoperative TR and did this have an
impact on the likelihood to maintain NSR?
Dr Yun. Patients with significant preoperative TR underwent
tricuspid annuloplasty, and TR disappeared postoperatively in
most of them. Therefore, we could not analyze the data in terms
of the relationship between postoperative TR and the time to the
first episode of AF recurrence. However, one thing for sure is
that this specific subset of patients is different from the cohort
with left heart disease, and right heart parameters (eg, right atrial654 The Journal of Thoracic and Cardiovascular Surgsize, TR grade, pulmonary artery pressure, or other things that
characterize the right heart) should be taken into account when
we assess the outcome of arrhythmia surgery in these patients.
Dr Pizarro. As you pointed out, this cohort was characterized
by advanced disease, older age, large left atrium, and persistent
AF. On the basis of these observations and considering the avail-
able evidence linking some of these variables to freedom from
recurrence, do you think that the choice of procedure, RA versus
BA, should be tailored to the presence of these factors? And if
so, what would be the thresholds you would suggest to match
patient to procedure, for example, left atrial size?
Dr Yun. That’s a tricky question to answer, and I have to admit
that I don’t have any idea about that. This study is a retrospective
review focusing on the difference of outcome between the 2 proce-
dural groups. To answer that question, we have to conduct a well-
designed prospective randomized clinical trial by putting in all the
variables including not only the left atrial size but also the right
heart parameters, as I pointed out, and produce a statistical model
that enables us to predict the benefit of each procedure. However, I
wouldn’t say that the RA is obsolete. Theremight be a subset of pa-
tients who may benefit from the RA. However, at this point, we
don’t have an answer for the question of who would best benefit
from right-sided only ablation in AF associated with ASD.
Dr Pizarro.Would you could comment on the fact that surger-
ies were performed by 5 surgeons with some differences in surgi-
cal technique and inconsistent use of alternative energy sources.
How do you think these factors influenced your observation and
have you standardized your surgical approach to these patients?
Dr Yun. As I said, 5 surgeons were involved in this study, and
there were subtle differences in surgical technique between the
surgeons in terms of the use of alternative energy sources. For in-
stance, 2 surgeons made the whole lesion 7 or 8 using cryothermia,
and others used a cryoprobe for only parts of them. Some surgeons
used microwave instead of cryothermia. Because of the complex-
ity of the use of alternative energy sources, I could not control this
compounding variable at the time of analysis. Rather, I would say
this study is based on the premise that the efficacy of alternative
energy sources is equal to that of cut-and-sew, as long as they
are applied endocardially. The second premise of this study is
that subtle differences in surgical technique did not affect the out-
come. This might not be true, but the surgical technique of the
maze operation is so diverse that we could not assess the impact
of minor technical modification on the long-term outcome.
Dr Pizarro. I enjoyed your presentation, and I congratulate you
and your colleagues on a well-written article.
Dr Christopher Caldarone (Toronto, Ontario, Canada). The
results you reported are somewhat at odds with the Mayo Clinic
report that describes reasonable efficacy with right atrial maze pro-
cedures. Now, their patient population was a bit different. They
had many more, I believe, intact atrial septa, many more patients
with pulmonary insufficiency, right ventricular dilation, and tricus-
pid insufficiency as their primary pathology. Do you think there is
a difference between patients with an intact atrial septum and pa-
tients with an ASD in terms of the efficacy of the RA?
Dr Yun. Of course, yes. In patients with ASD, especially in pa-
tients with a huge ASD, the left atrium is not free from pressure
volume overload because the right atrial pressure would be the
same as the left atrial pressure. Even if the left atrial size is normal,ery c March 2013
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Dthe left atrium might be pathologic, and that is the rationale for the
BA in this subset. For patients with an intact atrial septum, for
instance, in patients with Ebstein’s anomaly, the left atrium may
be protected, and the right atrial maze operation might be the
best way to go.
Dr Bahaaldin Alsoufi (Riyadh, Saudi Arabia). It’s been well
shown by the work of Haissaguerre from France and the original
work of Dr Cox that AF originates in the left atrium and flutter
originates in the right atrium. It’s not surprising to me that you
had a high failure rate with right atrial ablation only. My question
is do you think that those patients are different to justify creating
lesions in the right atrium alone?
I need to draw your attention to the presentation at the plenary
session yesterday morning from the Columbia University group.
They found no advantage of performing right-sided ablation on
top of left-sided ablation. It seems to me that left atrial ablation
is a must, whereas right atrial ablation should be added in patients
with flutter. Many electrophysiologists now would recommend not
addressing the right atrium at the time of surgery because it can be
easily addressed percutaneously at a later date if needed. So what
was your theory to make your group abandon left atrial ablation,
which not surprisingly was associated with a low success rate?
Dr Yun. The right-sided only concept was developed at the
Mayo Clinic, and I learned from them. A lot of congenital cardiac
surgeons who are not accustomed to arrhythmia surgery may hes-
itate to do the original Cox maze procedure for ASD because they
may not feel comfortable in cutting all the way down to the left
atrial auricle, isolating the left atrial auricle, and creating a cutting
lesion to the mitral valve. The concept from the Mayo Clinic that
the left atrium might be preserved in right heart disease has led us
to choose the right-side only maze procedure instinctively. With
the inference that the BA might be superior to the RA in this
setting, and, more important, with the development of an alterna-
tive energy source, BA has become an easy operation to perform
because it takes only 20 or 25 minutes of aortic crossclamping
for the left-sided maze operation and the rest of the procedure
can be done in the beating-heart condition.
Dr Alsoufi. So I think you have to do the left atrial maze.
Dr Yun. Right, I agree with that.The Journal of Thoracic and CaDr Frederic Jacques (Toronto, Ontario, Canada). In accor-
dance with the Cox studies and others, we know that the substrate
(the actual amount of atrial myocardium) influences the result. The
stripes of myocardium or the ‘‘corridors’’ organized as a maze
have to be small enough to prevent the propagation of thewavelets.
You said that right atria were enlarged in your patients, but was the
actual size of these atria at the end of the procedure similar be-
tween groups? Did you take some of the free wall out to downsize
these atria?
Dr Yun. Do you mean the size of the right atrium?
Dr Jacques. The right and left atria.
Dr Yun. We didn’t measure the right atrial size; thus, we can-
not compare the outcome in terms of the right atrial size. How-
ever, in this patient population, there were several patients who
had right atrial wall resection. The rationale for that procedure is
based on the experimental study by Dr Cox: To form a macro-
reentry circuit, we need 5- or 6-cm strips of atrial wall. Thus,
the basic principle of the maze procedure used in this cohort
was to make the atrial wall strip narrower than 4 cm. Although
there were 5 surgeons involved in this study, the basic surgical
principle was the same: Do not make the atrial wall strip wider
than 4 cm.
Dr Jacques. We know that in the postoperative period after
a maze procedure there is an increase in the rate of AF or atrial
arrhythmias that affects the atrial electrical remodeling. The use
of an antiarrhythmic drug in the early postoperative period may
affect this remodeling and influence the recurrence rate in the
long run. Can you comment on your perioperative management
protocol?
Dr Yun. The postoperative antiarrhythmic drug protocol was
different from one surgeon to another. Some used prophylactic an-
tiarrhythmic drugs even when NSR was restored. Some did not.
Approximately half of the patients had class 1 or 3 antiarrhythmic
drugs for 3 months postoperatively. If NSR is restored at 3 months
postoperatively, antiarrhythmic medication was no longer used in
most patients. In case of AF recurrence during the follow-up
period, another 3-month trial of antiarrhythmic medication was
attempted, and if this didn’t work, antiarrhythmic drugs were
switched to digoxin or beta-blockade.rdiovascular Surgery c Volume 145, Number 3 655
